Medartis Holding Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Matthias Schupp
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 3.8yrs |
Board average tenure | 3.7yrs |
Recent management updates
Recent updates
A Piece Of The Puzzle Missing From Medartis Holding AG's (VTX:MED) Share Price
Nov 27Medartis Holding (VTX:MED) Has A Rock Solid Balance Sheet
Nov 09The Strong Earnings Posted By Medartis Holding (VTX:MED) Are A Good Indication Of The Strength Of The Business
Aug 27Medartis Holding AG (VTX:MED) Doing What It Can To Lift Shares
Aug 21When Should You Buy Medartis Holding AG (VTX:MED)?
May 10Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation
Apr 11The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence
Feb 14Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Oct 24Is Medartis Holding (VTX:MED) A Risky Investment?
Oct 03Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value
Sep 06Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)
Jun 21Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital
Jan 31Why Medartis Holding AG (VTX:MED) Could Be Worth Watching
Oct 30These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat
Sep 07When Should You Buy Medartis Holding AG (VTX:MED)?
Jul 29Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
May 06At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?
Feb 08Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around
Jan 18We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt
Nov 10Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital
Sep 29Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital
Jun 08How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?
Mar 16We're Watching These Trends At Medartis Holding (VTX:MED)
Feb 09Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain
Jan 04What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?
Nov 19CEO
Matthias Schupp (60 yo)
less than a year
Tenure
Mr. Matthias Schupp is CEO & Member of the Executive Management Board of Medartis Holding AG from 2024. He had been Chief Executive Officer of Neodent at Straumann Holding AG since 2015 until 2024 and serv...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Vice Chairman | 26.9yrs | CHF 291.97k | 41.37% CHF 288.0m | |
CEO & Member of the Executive Management Board | less than a year | no data | no data | |
CFO & Member of the Executive Management Board | 3.8yrs | no data | 0.029% CHF 203.3k | |
VP of EMEA & Member of Executive Management Board | 4.3yrs | no data | 0.053% CHF 372.0k | |
CTO & Member of the Executive Board | 4.1yrs | no data | 0.017% CHF 118.1k | |
COO & Member of Management Board | 2.9yrs | no data | 0.0027% CHF 18.7k | |
Chief Human Resources Officer & Executive Management Board Member | no data | no data | no data | |
Head of Regulatory Affairs | 3.8yrs | no data | no data |
3.8yrs
Average Tenure
55yo
Average Age
Experienced Management: MED's management team is considered experienced (3.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Vice Chairman | 26.9yrs | CHF 291.97k | 41.37% CHF 288.0m | |
Independent Non-Executive Director | 6.9yrs | CHF 188.29k | 0.19% CHF 1.3m | |
Independent Chairman | 4.7yrs | CHF 568.06k | 0.065% CHF 452.7k | |
Independent Director | 2.7yrs | CHF 112.76k | 0.0096% CHF 67.0k | |
Independent Non Executive Director | 14.9yrs | CHF 161.68k | 4.55% CHF 31.6m | |
Independent Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | less than a year | no data | no data | |
Independent Director | 2.7yrs | CHF 171.53k | 0.0072% CHF 50.3k |
3.7yrs
Average Tenure
60.5yo
Average Age
Experienced Board: MED's board of directors are considered experienced (3.7 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:09 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medartis Holding AG is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Eric Le Berrigaud | Bryan Garnier & Co |
Hugo Solvet | Bryan Garnier & Co |
Christoph Gretler | Credit Suisse |